The deal will see the drug introduced in 127 countries globally, Kenya included. Once authorised, the drug will sell at Sh6,000, which is about $55. The pharmacy says this is the price the drug is sold at in South Africa. Sweeney said the production of the drug had already started in preparation for the authorisation by PPB. The drug is administered intravenously for five days at 200mg (two vials) on the first day and later 100mg on the subsequent four days.

Source: Standard Digital July 20, 2020 21:01 UTC